| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026346 Anticancer agents |
| 04/11/2006 | US7026336 4-pyridinylimidazol-2-ylhydrocarbyl amine, (thio)urea, carbamic acid or sulfonamide derivatives, e.g., (2-(4-(4-Chloro-3-methoxy-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl)-2-methyl-propyl)-carbamic acid tert-butyl ester; Raf kinase inhibitors for the treatment of neurotraumatic diseases |
| 04/11/2006 | US7026325 pyrazinoylguanidine compounds, e.g., 4-{4-[N-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidino]butyl}-N-(2-aminoethyl)benzamide hydrochloride; are absorbed less rapidly from mucosal surfaces, especially airway surfaces; rehydration of mucosal surfaces; reducing blood pressure |
| 04/11/2006 | US7026324 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 04/11/2006 | US7026323 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 04/11/2006 | US7026320 Serotonergic agents |
| 04/11/2006 | US7026314 Psychological disorders, antidepressants, anxiolytic agents, eating disorders; serotonin receptors antagonist |
| 04/11/2006 | CA2281702C (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 04/11/2006 | CA2199117C Compounds and methods for the treatment of cancer |
| 04/11/2006 | CA2187030C Improved anti-dandruff shampoo |
| 04/06/2006 | WO2006037117A1 Substituted heterocyclic compounds and methods of use |
| 04/06/2006 | WO2006036994A2 Modulators of crth2, cox-2 and faah |
| 04/06/2006 | WO2006036527A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | WO2006036507A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036497A2 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036404A1 4-(substituted cycloalkylmethyl) imidazole-2-thones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cyloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 04/06/2006 | WO2006036024A1 Proton pump inhibitors |
| 04/06/2006 | WO2006035770A1 Process for synthesis of derivatives, compound library, method for making the mase, and screening method |
| 04/06/2006 | WO2006035303A1 Muscarinic receptor antagonists |
| 04/06/2006 | WO2006035068A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/06/2006 | WO2006035067A2 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | WO2005102335A3 Methods of treating sleep disorders |
| 04/06/2006 | US20060074245 Reacting a 5-( beta -ketoalkyl)-3-substituted-1,2,4-oxadiazoles compound with hydrazine |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074243 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 04/06/2006 | US20060074238 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 04/06/2006 | US20060074128 Substituted 2-phenyl benzofurans as estrogenic agents |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074122 e.g., N-butyl-6-chloro-5-phenyl-1H-indazol-3-amine; kinase inhibitor; obesity and stroke; diseases involving phosphorylation of the tau protein such as Alzheimer's disease, Parkinson's disease, frontoparietal dementia |
| 04/06/2006 | US20060074116 3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | US20060074096 anti-cell prolifertive agents; 4-(1,2-diethylimidazol-5-yl)-2-{4-[N-(2-ethoxyethyl)sulphamoyl]anilino}pyrimidine; cancers, solid tumours, leukemias, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, hemangioma, nephropathies, atheroma, atherosclerosis, restenosis, autoimmune diseases, inflammation |
| 04/06/2006 | US20060074084 Inhibitors of soluble adenylate cyclase |
| 04/06/2006 | US20060074083 Cyclic and acyclic propenones for treating CNS disorders |
| 04/06/2006 | US20060074069 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders |
| 04/06/2006 | US20060074068 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 04/06/2006 | CA2582777A1 Proton pump inhibitors |
| 04/06/2006 | CA2582225A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | CA2581828A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581823A1 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581375A1 Specific kinase inhibitors |
| 04/06/2006 | CA2581254A1 Method for synthesizing derivative, compound library and method for constructing the same, and method for screening |
| 04/06/2006 | CA2580838A1 Substituted heterocyclic compounds and methods of use |
| 04/06/2006 | CA2577467A1 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | CA2573976A1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/05/2006 | EP1642895A2 Novel substituted naphthopyrans |
| 04/05/2006 | EP1641785A2 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhibitors |
| 04/05/2006 | EP1641784A1 4-(aminomethyl)-piperidine benzamides as 5ht4 -antagonists |
| 04/05/2006 | EP1641783A1 Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| 04/05/2006 | EP1641782A1 Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| 04/05/2006 | EP1641780A1 Processes for the preparation of 1- [(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 04/05/2006 | EP1641764A1 5-membered heterocycle-based p38 kinase inhibitors |
| 04/05/2006 | EP1641762A2 Cck-1 receptor modulators |
| 04/05/2006 | EP1641758A2 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP1140846B1 Aspartic protease inhibitors |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP1019372B1 Fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 04/05/2006 | CN1756756A Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 04/05/2006 | CN1756755A Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 04/05/2006 | CN1756754A Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 04/05/2006 | CN1756753A Benzofuran derivative |
| 04/05/2006 | CN1756746A 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1249058C Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use |
| 04/05/2006 | CN1249057C Chromenylmethyl pyrimidinediamines as antibacterial agents |
| 04/05/2006 | CN1249052C Pyrazole derivatives as HIV reverse transcriptase inhibitors |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/05/2006 | CN1249044C Chromanone derivatives |
| 04/05/2006 | CN1249043C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/05/2006 | CN1249036C Iron chelators and use thereof |
| 04/04/2006 | US7022733 Estrogen receptor modulators for treating or inhibiting endometriosis |
| 04/04/2006 | US7022732 6-substituted 2,3-dihydro-1,4-benzodioxine, 2-position substituted with carboxy, or (C1 C6)alkoxycarbonyl; diabetes, obesity; 6-[2-(R)-[2-(S)-hydroxy-3-(4-hydroxy-3-methanesulfonamido-phenoxy)propylamino]propyl]-2,3-dihydro-1,4-benzodioxine-2-(R)-carboxylic acid; B3 andrenergic receptor agonist |
| 04/04/2006 | US7022731 Cardiovascular disorders; thrombosis; anticoagulants |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022723 Heterocyclic compounds |
| 04/04/2006 | US7022718 Pyridine and pyrimidine derivatives |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022696 Treatment of airway disorders |
| 04/04/2006 | US7022492 Ecstasy haptens and immunogens |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 04/04/2006 | CA2241787C Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
| 04/04/2006 | CA2235133C Esters of 3-hydroxy-piperidinemethanol derivatives |
| 04/04/2006 | CA2198266C Novel benzimidazole derivatives |
| 04/04/2006 | CA2193039C Indol-2-one derivatives |
| 04/04/2006 | CA2166315C Process for the preparation of thalidomide |
| 04/04/2006 | CA2043976C Substituted phthalides and heterocyclic phthalides |
| 03/30/2006 | WO2006034234A1 Crystalline form 3 of atrasentan hydrochloride |
| 03/30/2006 | WO2006034116A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 03/30/2006 | WO2006034094A1 Crystalline form 1 of atrasentan hxdrochloride |
| 03/30/2006 | WO2006034085A1 Crystalline form of atrasentan hydrochloride |
| 03/30/2006 | WO2006034084A1 Crystalline form 2 of atrasentan hydrochloride |
| 03/30/2006 | WO2006033631A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| 03/30/2006 | WO2006033630A1 Compounds, compositions containing them, preparation thereof and uses thereof iii |
| 03/30/2006 | WO2006033627A1 Compounds, compositions containing them, preparation thereof and uses thereof iiii |
| 03/30/2006 | WO2006033620A1 New heterocyclic amides |
| 03/30/2006 | WO2006033002A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |